GBS Inc.
NASDAQ: GBS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Harry Simeonidis
- Employees
- 12
- Headquarters
- New York City, United States
- IPO year
- 2020
- Market cap
- $433.6K
- Website
- https://gbs.inc
Loading GBS…
Loading profile data…Frequently asked questions about GBS
What does GBS Inc. (GBS) do?
Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2...
Where does GBS trade?
GBS Inc. (GBS) trades on the NASDAQ Global Market.
What sector is GBS in?
GBS Inc. (GBS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of GBS Inc.?
Harry Simeonidis is the chief executive officer of GBS Inc. (GBS).
Where is GBS Inc. headquartered?
GBS Inc. is headquartered in United States.
Does GBS pay a dividend?
GBS Inc. (GBS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GBS go public?
GBS Inc. (GBS) completed its initial public offering in 2020.